Logo

BGI Extends Offer for Complete Genomics Again

Feb 04, 2013 | staff reporter

NEW YORK (GenomeWeb News) – BGI-Shenzhen has again extended its cash tender offer for Complete Genomics, the firm said Friday.

The $118 million offer already has been extended a few times as BGI awaits approval from China's Ministry of Commerce and the State Administration of Foreign Exchange.

The offer is now set to expire at midnight EST on Feb. 6. It was previously extended to midnight on Feb. 1.

As of the close of business on Friday, approximately 30,836,847 shares representing 87 percent of Complete Genomics' outstanding stock had been validly tendered and not withdrawn.

Filed under

Clinical Sequencing
Sequencing
Business News
tender offer
mergers & acquisitions
MGI Tech
BGI
Breaking News
The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.